APA (7th ed.) Citation

Hui Zhao, Zi-Ran Li, Qian Zhang, Ming-Kang Zhong, Ming-Ming Yan, & Xiao-Yan Qiu. (2023). Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hui Zhao, Zi-Ran Li, Qian Zhang, Ming-Kang Zhong, Ming-Ming Yan, and Xiao-Yan Qiu. Sodium-glucose Co-transporter-2 Inhibitor (SGLT2i) Treatment and Risk of Osteomyelitis: A Pharmacovigilance Study of the FAERS Database. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Hui Zhao, et al. Sodium-glucose Co-transporter-2 Inhibitor (SGLT2i) Treatment and Risk of Osteomyelitis: A Pharmacovigilance Study of the FAERS Database. Frontiers Media S.A., 2023.